104.59
price up icon0.56%   +0.58
after-market  アフターアワーズ:  104.47  -0.12   -0.11%
loading

Abbott Laboratories (ABT) 最新ニュース

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

pulisher
Zacks Investment Research

Got $1,000? 3 Dividend Stocks to Buy and Hold Forever

pulisher
The Motley Fool

The Zacks Analyst Blog Highlights Tesla, Johnson & Johnson, Netflix, Abbott and ConocoPhillips

pulisher
Zacks Investment Research

Q1 Earnings Season Scorecard and Fresh Analyst Reports for Tesla, JNJ & Netflix

pulisher
Zacks Investment Research

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

pulisher
Zacks Investment Research

PBH vs. ABT: Which Stock Is the Better Value Option?

pulisher
Zacks Investment Research

2 Beaten-Down Dividend Stocks to Buy and Hold Forever

pulisher
The Motley Fool

Better Dividend Stock: AbbVie or Johnson & Johnson?

pulisher
The Motley Fool

3 Dividend Stocks to Buy and Hold for the Next Decade

pulisher
The Motley Fool

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

pulisher
Zacks Investment Research

Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably

pulisher
Seeking Alpha

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

pulisher
Zacks Investment Research

Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario

pulisher
Seeking Alpha

Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?

pulisher
Benzinga

Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript

pulisher
The Motley Fool

Q1 Earnings Review

pulisher
Zacks Investment Research

Markets Try to Shake Off April Blues

pulisher
Zacks Investment Research

Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract

pulisher
Zacks Investment Research

Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings

pulisher
Benzinga

Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say

pulisher
Zacks Investment Research

Abbott (ABT) Tops Q1 Earnings and Revenue Estimates

pulisher
Zacks Investment Research

Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point

pulisher
Benzinga

Investor Optimism Decreases; Dow Ends 6-Session Losing Streak

pulisher
Benzinga

Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday

pulisher
Benzinga

Markets Mixed as Q1 Earnings, Powell Control News Headlines

pulisher
Zacks Investment Research

Wall Street Breakfast: The Week Ahead

pulisher
Seeking Alpha

3 Buy Rated Stocks to Consider as Earnings Approach

pulisher
Zacks Investment Research

What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?

pulisher
Zacks Investment Research

Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

pulisher
Zacks Investment Research

Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer

pulisher
Benzinga

Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable

pulisher
Zacks Investment Research

Got $200? 2 Healthcare Stocks to Buy and Hold Forever.

pulisher
The Motley Fool

Abbott (ABT) Rises Higher Than Market: Key Facts

pulisher
Zacks Investment Research

HAE vs. ABT: Which Stock Is the Better Value Option?

pulisher
Zacks Investment Research

Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'

pulisher
Benzinga

3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade

pulisher
The Motley Fool

Abbott (ABT) Faces Low Testing Demand, Currency Headwinds

pulisher
Zacks Investment Research

The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services

pulisher
Zacks Investment Research

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

pulisher
Zacks Investment Research

3 Top Dividend Stocks to Buy in April 2024

pulisher
The Motley Fool

Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks

pulisher
Zacks Investment Research

Abbott (ABT) Receives FDA's Approval for the TriClip TEER System

pulisher
Zacks Investment Research

Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?

pulisher
Zacks Investment Research

Analyst Ratings For Abbott Laboratories

pulisher
Benzinga

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

pulisher
Zacks Investment Research

Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval

pulisher
Zacks Investment Research

Abbott (ABT) Declines More Than Market: Some Information for Investors

pulisher
Zacks Investment Research

3 'Great Repeatable Business Models' (Dividend Aristocrats)

pulisher
Seeking Alpha

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

pulisher
Zacks Investment Research

Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark

pulisher
Zacks Investment Research
medical_devices SYK
$331.99
price up icon 2.37%
medical_devices MDT
$84.72
price up icon 0.50%
medical_devices BSX
$74.45
price up icon 1.31%
medical_devices EW
$90.16
price up icon 4.28%
$129.71
price up icon 2.97%
大文字化:     |  ボリューム (24 時間):